Press release
Diabetic Nephropathy Market to Reach an expected value of USD 3,145.9 million in 2027
Diabetic Nephropathy Market 2022-2027
The Diabetic Nephropathy Market is bound to grow robustly in the years to come. With smart technology and 5G being increasingly adopted, the healthcare vertical is witnessing a paradigm shift. These technologies can thus increase the convenience quotient (CQ), as abysmal disruption happens in the patients' lives. This convenience quotient would be the trend running in the healthcare vertical shortly.
According to a new market report published by Persistence Market Research "Global Market Study on Diabetic Nephropathy Market - Asia to Witness Highest Growth by 2027,".The global diabetic nephropathy market was valued at USD 2,262.2 million in 2022 and is expected to grow at a CAGR of 5.6% from 2022 to 2027, to reach an expected value of USD 3,145.9 million in 2027.
Get Free Sample Copy of this Report@ https://www.persistencemarketresearch.com/samples/3594
Diabetic nephropathy is a disease of the kidney glomerulus and one of the most significant complications in terms of mortality and morbidity for patients with diabetes. Globally, the diabetic nephropathy market is witnessing significant growth due to increasing prevalence of diabetes and obesity in different regions of the world.
In addition, increasing R&D investments in drug discovery and development and raising awareness about diabetes and kidney-related disorders are also driving the growth of the market. However, stringent regulatory requirements and longer approval time for drugs as well as the lack of comprehensive therapeutic management for diabetic nephropathy are inhibiting the growth of diabetic nephropathy market.
Some of the major players in the diabetic nephropathy market:
Novartis AG, Merck & Co., Inc.
Pfizer, Inc.
Abbott Laboratories.
Sanofi.
Eli Lilly.
Company.
Reata Pharmaceuticals, Inc.
Bayer AG, AbbVie, Inc.
Mitsubishi Tanabe Pharma Corporation.
Other
Request for Methodology@ https://www.persistencemarketresearch.com/methodology/3594
In North America, various government programs are spreading awareness about diabetes and related renal complications. For instance, the National Kidney Disease Education Program, one of the major programs organized by the U.S. government, for increasing awareness about the various kidney diseases. In addition, the number of diabetic patients are also increasing in the region; according to the SciELO Public Health, approximately 35 million people were affected with diabetes mellitus in 2000 and this number is expected to reach 64 million by 2025 in North America.
In Europe, rise in healthcare expenditure for diabetes treatment and increasing prevalence of diabetes in the various part of Europe is boosting the growth of the European diabetic nephropathy market. According to IDF, approximately 55.4 million people had diabetes in 2010 and the number is expected to reach 66.5 million by 2030 in Europe. According to the IDF, healthcare expenditure for diabetes treatment was approximately USD 105.5 billion in 2010 and is expected to reach USD 124.6 billion by 2030 in Europe.
Asia represents the fastest growing region in the diabetic nephropathy market due to the rise in a diabetic population in various countries such as Japan and the Southeast Asian countries. According to the International Diabetes Federation (IDF), developing countries, such as India and China, are expected to have the highest number of diabetes mellitus patients compared to developed countries, such as the U.S. and Germany.
The global diabetic nephropathy market is segmented as follows:
Diabetic nephropathy market, by model of treatment
Disease Modifying Therapies
Angiotensin-Converting Enzyme Inhibitors
Angiotensin Receptor Blockers
Diuretics
Calcium Channel Blockers
Renin Inhibitors
Connective Tissue Growth Factor Inhibitors
Antioxidant Inflammation Modulator
Monocyte Chemoattractant Proteins Inhibitor
Endothelin-A Receptor Antagonist
G Protein-Coupled Receptors
Access Full Report@ https://www.persistencemarketresearch.com/checkout/3594
Key Questions Answered in the Diabetic Nephropathy Market Report
How is the Diabetic Nephropathy market expected to grow over the projected period?
What direction is the Diabetic Nephropathy market expected to take in terms of volume and value during the forecast period?
What is the impact of macroeconomic factors on the Diabetic Nephropathy market in future?
What are the key market drivers in the Diabetic Nephropathy market?
What are significant opportunities and improvement areas for Diabetic Nephropathy manufacturers?
What are the key developments and trends taking over the Diabetic Nephropathy market?
Which are the emerging countries that are expected to create significant growth opportunities in the Diabetic Nephropathy market?
Contact Us:
Persistence Market Research
Address - 305 Broadway, 7th Floor, New York City, NY 10007 United States
U.S. Ph. - +1-646-568-7751
USA-Canada Toll-free - +1 800-961-0353
Sales - sales@persistencemarketresearch.com
About Us:
PersistenceMarketResearch is an esteemed company with a reputation of serving clients across domains of information technology (IT), healthcare, and chemicals. Our analysts undertake painstaking primary and secondary research to provide a seamless report with a 360 degree perspective. Data is compared against rep/uted organizations, trustworthy databases, and international surveys for producing impeccable reports backed with graphical and statistical information.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Diabetic Nephropathy Market to Reach an expected value of USD 3,145.9 million in 2027 here
News-ID: 2590316 • Views: …
More Releases from Persistence Market Research
IV Fluid Transfer Drug Devices Market to Grow at a CAGR of 3.5% from 2023 to 203 …
Introduction
The IV fluid transfer drug devices market has gained significant momentum in recent years due to its vital role in ensuring safe, accurate, and sterile administration of intravenous therapies across healthcare settings. These devices are designed to facilitate efficient transfer of fluids and medications from containers to patients, minimizing the risk of contamination, dosage errors, and healthcare-associated infections. They are widely used in hospitals, ambulatory surgical centers, homecare, and specialty…
Urolithiasis Management Devices Market Set to Grow and Garner a Share of US$ 2.2 …
Introduction
The urolithiasis management devices market has witnessed significant growth in recent years, driven by the increasing prevalence of kidney stones and advancements in minimally invasive treatment options. Urolithiasis, or the formation of stones in the urinary tract, is a growing global health concern linked to changing dietary habits, sedentary lifestyles, and rising incidences of metabolic disorders such as obesity and diabetes. Management devices play a crucial role in the diagnosis,…
Endoscopic Closure Systems Market Set to Grow at a 6.7% CAGR, Crossing the US$ 4 …
Introduction
The endoscopic closure systems market has witnessed remarkable growth in recent years due to their critical role in minimally invasive surgical procedures. These systems are primarily used to close gastrointestinal perforations, resection sites, fistulas, and leaks, offering a safe and effective alternative to traditional open surgeries. Known for their efficiency, precision, and patient safety benefits, endoscopic closure systems have become indispensable in gastroenterology, bariatric surgery, oncology, and other medical specialties.
Request…
At-Home Molecular Testing Market to Reach US$16.3 Bn by 2030, Growing at 6.0% CA …
Introduction
The at-home molecular testing market has gained remarkable momentum in recent years, driven by the growing demand for accessible, convenient, and accurate diagnostic solutions. Leveraging advanced molecular technologies such as PCR and isothermal amplification, these tests enable users to detect infectious diseases, genetic conditions, and other health-related biomarkers without visiting traditional healthcare facilities. The increasing focus on patient-centric care, rising awareness about preventive health, and technological advancements in miniaturized diagnostic…
More Releases for Diabetic
Diabetic Socks Market Dynamics Shaped by Rising Diabetic Population - Persistenc …
The diabetic socks market is gaining significant traction worldwide, driven by the rising prevalence of diabetes and related complications such as diabetic neuropathy and foot ulcers. Designed specifically to cater to the needs of diabetic patients, these socks play a crucial role in foot protection by preventing blistering, reducing moisture accumulation, and providing cushioning to minimize the risk of ulcers. This article delves deeply into the diabetic socks market, exploring…
Leading Element Driving Change in the Diabetic Footwear Market in 2025: Rising D …
Which drivers are expected to have the greatest impact on the over the diabetic footwear market's growth?
The surge in people with diabetes will spur the expansion of the diabetic footwear market in the future. Diabetes, characterised by high blood sugar levels, is a long-term health issue. Diabetic footwear can prevent severe foot-related issues caused by diabetes and offer several advantages such as enhanced blood flow, ample space for the toes,…
Diabetic Food Market
Future Market Insights (FMI) delivers key insights on the global diabetic food market in its latest report titled “Diabetic Food Market: Global Industry Analysis and Opportunity Assessment, 2014 – 2020”. The global diabetic food market is expected to amplify at a CAGR of 5.9% during the forecast period in terms of value due to various factors, regarding which FMI offers fundamental insights in detail in this report.
On the basis of…
Diabetic Food Market
Diabetes refers to a metabolic disease which leads to high blood sugar levels. The main cause behind diabetes is the insufficient insulin or no response in the body cells where the insulin is produced. Diabetic foods are dietary products rich in carbohydrates and sugar content. They help in controlling rising blood glucose. Diabetic food is low in calorie sweeteners and diet beverages. These products are consumed by diabetic patients and…
Demand for Diabetic Socks Due to Rising Prevalence of Diabetic Neuropathy Expect …
According to the latest market report published by Persistence Market Research titled ‘Diabetic Socks Market: Global Industry Analysis 2012-2016 and Forecast 2017-2025,’ the global diabetic socks market is expected to expand at a CAGR of approximately 4.8% during the forecast period 2017-2025.
To know key findings Request Sample Report @: https://www.persistencemarketresearch.com/samples/19282
Global Diabetic Socks Market: Factors Impacting the Market
The primary factors driving the growth of the global diabetic socks market are increasing…
Diabetic Food Market -
In recent times, diabetes has emerged as one of the most challenging health conditions across the world. According to the WHO, a total of 415 million cases of diabetes were reported globally in 2015. The count is rising at an alarming rate and is expected to reach 642 million in the next 25 years. Till now no medication has been found that can completely cure diabetes. It can only be…
